METASTATIC HER2-POSITIVE BREAST CANCER
Clinical trials for METASTATIC HER2-POSITIVE BREAST CANCER explained in plain language.
Never miss a new study
Get alerted when new METASTATIC HER2-POSITIVE BREAST CANCER trials appear
Sign up with your email to follow new studies for METASTATIC HER2-POSITIVE BREAST CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo aims to tame aggressive breast cancer
Disease control OngoingThis study tests a different dosing schedule of the chemotherapy drug capecitabine combined with the targeted therapy neratinib in people with advanced HER2-positive breast cancer. The goal is to find the safest dose that still works. About 34 adults with stage IV breast cancer t…
Matched conditions: METASTATIC HER2-POSITIVE BREAST CANCER
Phase: PHASE1, PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
New imaging tracer could sharpen detection of aggressive breast cancer
Diagnosis OngoingThis pilot study tests a special PET scan using a radioactive tracer called 64Cu-DOTA-trastuzumab in 18 women with advanced HER2-positive breast cancer. The goal is to see if this scan can better identify HER2-positive tumors compared to standard imaging. If it works, it may help…
Matched conditions: METASTATIC HER2-POSITIVE BREAST CANCER
Phase: NA • Sponsor: City of Hope Medical Center • Aim: Diagnosis
Last updated Jun 27, 2026 07:57 UTC